| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2022 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 08/10/2022 | 72.97% | Morgan Stanley | → $16 | Downgrades | Overweight → Underweight |
| 11/29/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
What is the target price for Evotec (EVO)?
The latest price target for Evotec (NASDAQ: EVO) was reported by Deutsche Bank on November 16, 2022. The analyst firm set a price target for $0.00 expecting EVO to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Evotec (EVO)?
The latest analyst rating for Evotec (NASDAQ: EVO) was provided by Deutsche Bank, and Evotec downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Evotec (EVO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evotec, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evotec was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
Is the Analyst Rating Evotec (EVO) correct?
While ratings are subjective and will change, the latest Evotec (EVO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Evotec (EVO) is trading at is $9.25, which is out of the analyst's predicted range.